NRSN

NASDAQ 已收盘

NeuroSense Therapeutics

1.28 USD
▲+0.02+1.59%
盘后 1.28 -0.10%
2026-11-20
市值
$2.37M
市盈率
—
EPS
-8.73
股息率
—
52 周区间
1.10 – 24.80
成交量
9.55K
Beta
1.72
目标价
91.75
52W 低 1.1052W 高 24.80
价格走势

公司简介

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company’s lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer’s, as well as under preclinical stu...